Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 18, Issue 2, 2011, Pages 268-275

  Caralt, Mireia ^a   Martí, Josep ^b   Cortés, Javier ^a   Fondevila, Constantino ^b   Bilbao, Itxarone ^a   Fuster, Josep ^b   García Valdecasas, Juan Carlos ^b   Sapisochín, Gonzalo ^a   Balsells, Joaquim ^a   Charco, Ramón ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Liver metastases; Melanoma; Surgical treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS MELANOMA; EMERGENCY SURGERY; EYE CANCER; EYE MELANOMA; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MALE; MELANOMA; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE PERIOD; PRIMARY TUMOR; SKIN CANCER; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR BLEEDING; VISCERAL METASTASIS;

ADULT; AGED; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SPAIN; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79959848026     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-010-0341-x     Document Type: Article

References (30)

1. Lee ML, Tomsu K, Von Eschen KB. Duration of survival for disseminated malignant melanoma. Results of a meta-analysis. Melanoma Res. 2000;10:81-92.
2. Albert DM, Ryan LM, Borden EC. Metastatic ocular and cutaneous melanoma: a comparison of patient characteristics and prognosis. Arch Ophthalmol. 1996;114:107-8. (Pubitemid 26026209)
3. Becker JC, Terheyden P, Kämpgen E, Wagner S, Neuman C, Schadendorf D, et al. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha and interleukin 2. Br J Cancer. 2002;87:840-5. (Pubitemid 35252958)
4. Li Y, McClay EF. Systemic chemotherapy for the treatment of metastatic melanoma. Semin Oncol. 2002;29:413-26. (Pubitemid 35178281)
5. Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, et al. Hepatic resection for noncolorectal nonendocrine liver metastases. Analysis of 1452 patients and development of a prognostic model. Ann Surg. 2006;244:524-35.
6. Billingsley KG, Burt ME, Jara E, Ginsberg RJ, Woodruff JM, Leung DH, et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg. 1999;229(5):602-10.
7. Martí J, Modolo MM, Fuster J, Comas J, Cosa R, Ferrer J, et al. Prognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: a single-center analysis. World J Gastroenterol. 2009;15:2587-94.
8. Caralt M, Bilbao I, Cortés J, Escartín A, Lázaro JL, Dopazo C, et al. Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancer. Ann Surg Oncol. 2008;15:2804-10.
9. Leo F, Cagini L, Rocmans P, Cappello M, Geel AN, Maggi G, et al. Lung metastases from melanoma: when is surgical treatment warranted? Br J Cancer. 2000;83:569-72.
10. Agrawal S, Yao TJ, Coit DG. Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol. 1999;6:336-44. (Pubitemid 29260795)
11. Haigh PI, Essner R, Wardlaw JC, Stern SL, Morton DL. Longterm survival after complete resection of melanoma metastatic to the adrenal gland. Ann Surg Oncol. 1999;6:633-9.
12. Weitz J, Blumgart LH, Fong Y, Jarnagin WR, D'Angelica M, Harrison LE, et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann Surg Oncol. 2005;12:459-66.
13. Vauthey JN, Winter MW, Blumgart LH. Solitary metastasis from cutaneous melanoma to the liver: resection by extended left hepatectomy (trisegmentectomy) with clearance of tumor from the portal vein. HPB Surg. 1994;8:53-6. (Pubitemid 24254173)
14. Dousei T, Miyata M, Yamaguchi T, Nagaoka M, Takahashi E, Kawashima Y. Rupture of liver metastasis of malignant melanoma - a case of hepatic resection. Jpn J Surg. 1991;21:480-4.
15. Wood T, DiFronzo A, Rose DM, Haigh Pl, Stern SL, Wanek L, et al. Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol. 2001;8:658-62.
16. Young S, Martinez S, Essner R. The role of surgery in treatment of stage IV melanoma. J Surg Oncol. 2006;94:344-51. (Pubitemid 44330859)
17. Rose DM, Essner R, Hughes TM, Tang PC, Bilchik A, Wanek LA, et al. Surgical resection for metastatic melanoma to the liver. Arch Surg. 2001;136:950-5.
18. Hsueh EC, Essner R, Foshag LJ, Ye X, Wang HJ, Morton DL. Prolonged survival after complete resection of metastases from intraocular melanoma. Cancer. 2004;100:122-9. (Pubitemid 37553547)
19. Kodjikian L, Grange JD, Baldo S, Baillif S, Garweg JG, Rivoire M. Prognostic factors of liver metastases from uveal melanoma. Grafe's Arch Clin Exp Ophthalmol. 2005;243:985-93. (Pubitemid 41631038)
20. Crook TB, Jones OM, John TG, Rees M. Hepatic resection for malignant melanoma. Eur J Surg Oncol. 2006;32:315-7.
21. Pawlick TM, Zorzi D, Abdalla EK, Clary BM, Gershenwald JE, Ross MI, et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol. 2006;13:712-20.
22. Herman P, Machado M, Montagnini AL, D'Albuquerque LA, Saad WA, Machado MC. Selected patients with metastatic melanoma from liver resection. World J Surg. 2007;31:171-4. (Pubitemid 46089562)
23. Aoyama T, Mastrangelo MJ, Berd D, Nathan FE, Shields CL, Shields JA, et al. Protracted survival after resection of metastatic uveal melanoma. Cancer. 2000;89:1561-8.
24. Van Iersel LB, Hoekman EJ, Gelderblom H, Vahrmeijer AL, van Meerten EL, Tijl FG, et al. Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases. Ann Surg Oncol. 2008;15:1891-8.
25. Alexander HR Jr, Libutti SK, Pingpank JF, Steinberg SM, Bartlett DL, Helsabeck C, et al. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to the liver. Clin Cancer Res. 2003;9:6343-9. (Pubitemid 38031818)
26. Siegel R, Hauschild A, Kettelhack C, Kähler KC, Bembenek A, Schlag PM. Hepatic arterial fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma. Eur J Surg Oncol. 2007;33:627-32. (Pubitemid 46746527)
27. Sharma KV, Gould JE, Harbour JW, Linette GP, Pilgram TK, Dayani PN, et al. Hepatic arterial chemoembolization for management of metastatic melanoma. AJR Am J Roentgenol. 2008;190:99-104.
28. Feldman ED, Pingpank JF, Alexander HR Jr. Regional treatment options for patients with ocular melanoma metastatic to the liver. Ann Surg Oncol. 2004;11:290-7. (Pubitemid 40486769)
29. Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, Plaud B, Ducreux M, Spielmann M, et al. Resection of liver metastases from noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg. 1998;187:487-92.
30. Lang H, Nussbaum KT, Weimann A, Raab R. Liver resection for non-colorectal, non-endocrine hepaticmetastases.Chirurg. 1990;70:439-46.